Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest HighVista Strategies LLC Stock Portfolio

$280Million– No. of Holdings #130

HighVista Strategies LLC Performance:
2024 Q1: 5.12%YTD: 5.12%2023: 15.41%

Performance for 2024 Q1 is 5.12%, and YTD is 5.12%, and 2023 is 15.41%.

About HighVista Strategies LLC and 13F Hedge Fund Stock Holdings

HighVista Strategies LLC is a hedge fund based in BOSTON, MA. On 27-Jun-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $4.9 Billions. In it's latest 13F Holdings report, HighVista Strategies LLC reported an equity portfolio of $280.4 Millions as of 31 Mar, 2024.

The top stock holdings of HighVista Strategies LLC are DBC, , AGLE. The fund has invested 11.8% of it's portfolio in INVESCO DB COMMDY INDX TRCK and 2.8% of portfolio in APOGEE THERAPEUTICS INC.

The fund managers got completely rid off IMMUNOVANT INC (IMVT), IMMUNOGEN INC (IMGN) and SPLUNK INC (SPLK) stocks. They significantly reduced their stock positions in SPYRE THERAPEUTICS INC (AGLE), 4D MOLECULAR THERAPEUTICS IN (FDMT) and MASTERCARD INCORPORATED (MA). HighVista Strategies LLC opened new stock positions in APOGEE THERAPEUTICS INC, ANSYS INC (ANSS) and JUNIPER NETWORKS INC (JNPR). The fund showed a lot of confidence in some stocks as they added substantially to ARGENX SE (ARGX), ROIVANT SCIENCES LTD (ROIV) and AMAZON COM INC (AMZN).
HighVista Strategies LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

HighVista Strategies LLC Annual Return Estimates Vs S&P 500

Our best estimate is that HighVista Strategies LLC made a return of 5.12% in the last quarter. In trailing 12 months, it's portfolio return was 23.45%.

New Buys

Ticker$ Bought
apogee therapeutics inc7,934,330
ansys inc4,443,650
juniper networks inc4,250,780
vaneck etf trust2,776,240
keros therapeutics inc2,595,570
springworks therapeutics inc2,509,580
orthofix med inc2,437,910
maplebear inc2,326,900

New stocks bought by HighVista Strategies LLC

Additions

Ticker% Inc.
argenx se532
roivant sciences ltd286
amazon com inc157
intra-cellular therapies inc154
madrigal pharmaceuticals inc77.08
ascendis pharma a/s60.08
alibaba group hldg ltd56.81
hdfc bank ltd56.41

Additions to existing portfolio by HighVista Strategies LLC

Reductions

Ticker% Reduced
spyre therapeutics inc-73.27
4d molecular therapeutics in-61.5
mastercard incorporated-57.88
structure therapeutics inc-49.96
trip com group ltd-47.66
first ctzns bancshares inc n-43.07
alpine immune sciences inc-42.84
revolution medicines inc-36.75

HighVista Strategies LLC reduced stake in above stock

Sold off

Ticker$ Sold
ambrx biopharma inc-2,892,460
sovos brands inc-4,066,740
cymabay therapeutics inc-3,787,090
immunogen inc-4,292,490
teva pharmaceutical inds ltd-1,301,870
uipath inc-3,072,090
immunovant inc-5,109,820
pnm res inc-2,908,210

HighVista Strategies LLC got rid off the above stocks

Sector Distribution

HighVista Strategies LLC has about 35% of it's holdings in Healthcare sector.

Sector%
Healthcare35
Others30.2
Technology10.8
Industrials6.2
Consumer Cyclical4.6
Consumer Defensive3.6
Energy3.4
Communication Services3
Financial Services2.2

Market Cap. Distribution

HighVista Strategies LLC has about 27.2% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
UNALLOCATED30.2
MID-CAP26.4
LARGE-CAP18.1
SMALL-CAP14.3
MEGA-CAP9.1
MICRO-CAP1.7

Stocks belong to which Index?

About 0% of the stocks held by HighVista Strategies LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others100
Top 5 Winners (%)%
ALPN
alpine immune sciences inc
89.1 %
MRUS
merus n v
63.4 %
COIN
coinbase global inc
59.7 %
GERN
geron corp
56.4 %
NU
nu hldgs ltd
53.9 %
Top 5 Winners ($)$
AGLE
spyre therapeutics inc
3.2 M
MRUS
merus n v
2.3 M
BCYC
bicycle therapeutics plc
1.1 M
IDYA
ideaya biosciences inc
1.1 M
ACLX
arcellx inc
1.0 M
Top 5 Losers (%)%
IMRX
immuneering corp
-60.7 %
RPTX
repare therapeutics inc
-35.5 %
CABA
cabaletta bio inc
-23.4 %
BBIO
bridgebio pharma inc
-20.9 %
VRDN
viridian therapeutics inc
-19.6 %
Top 5 Losers ($)$
IMRX
immuneering corp
-1.1 M
VRDN
viridian therapeutics inc
-0.8 M
OLMA
olema pharmaceuticals inc
-0.7 M
MLTX
moonlake immunotherapeutics
-0.6 M
INSM
insmed inc
-0.5 M

HighVista Strategies LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of HighVista Strategies LLC

HighVista Strategies LLC has 130 stocks in it's portfolio. About 28.7% of the portfolio is in top 10 stocks. IMRX proved to be the most loss making stock for the portfolio. AGLE was the most profitable stock for HighVista Strategies LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions